Editorial: The Molecular Mechanisms of Epilepsy and Potential Therapeutics
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Belisheva N, Drogobuzhskaya S Biology (Basel). 2024; 13(8).
PMID: 39194565 PMC: 11351456. DOI: 10.3390/biology13080626.
References
1.
Shlobin N, Sander J
. Learning from the comorbidities of epilepsy. Curr Opin Neurol. 2021; 35(2):175-180.
DOI: 10.1097/WCO.0000000000001010.
View
2.
Moshe S, Perucca E, Ryvlin P, Tomson T
. Epilepsy: new advances. Lancet. 2014; 385(9971):884-98.
DOI: 10.1016/S0140-6736(14)60456-6.
View
3.
Pitkanen A, Engel Jr J
. Past and present definitions of epileptogenesis and its biomarkers. Neurotherapeutics. 2014; 11(2):231-41.
PMC: 3996117.
DOI: 10.1007/s13311-014-0257-2.
View
4.
Allers K, Essue B, Hackett M, Muhunthan J, Anderson C, Pickles K
. The economic impact of epilepsy: a systematic review. BMC Neurol. 2015; 15:245.
PMC: 4660784.
DOI: 10.1186/s12883-015-0494-y.
View
5.
Loscher W
. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments. Neuropharmacology. 2019; 167:107605.
DOI: 10.1016/j.neuropharm.2019.04.011.
View